Prostatic Neoplasms: all 6,484 studies
Page 26 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00110214Phase 3Results posted
- A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate CancerCompletedNCT00108732Phase 2Results posted
- Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate CancerTerminatedNCT00103376Phase 2Results posted
- Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate CancerCompletedNCT00103194Phase 2Results posted
- Radiation Therapy in Treating Patients With Stage II or Stage III Prostate CancerCompletedNCT00091390Phase 2Results posted
- A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate CancerCompletedNCT00090545Phase 2Results posted
- ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)CompletedNCT00090363Phase 2Results posted
- AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate CancerCompletedNCT00089674Phase 3Results posted
- Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate CancerCompletedNCT00089609Phase 2Results posted
- Ixabepilone in Treating Patients With Metastatic Prostate CancerCompletedNCT00087139Phase 2Results posted
- Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate CancerCompletedNCT00085566Phase 1/2Results posted
- Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the ProstateTerminatedNCT00084864Phase 2Results posted
- Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate CancerCompletedNCT00084552Not applicableResults posted
- Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone MetastasesCompletedNCT00081159Phase 2Results posted
- Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate CancerCompletedNCT00080899Phase 2Results posted
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesCompletedNCT00079001Phase 3Results posted
- Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyCompletedNCT00065442Phase 3Results posted
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00063882Phase 3Results posted
- Sequential Vaccinations in Prostate Cancer PatientsCompletedNCT00060528Phase 1/2Results posted
- Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate CancerCompletedNCT00058539Phase 2Results posted
- Perifosine in Treating Patients With Recurrent Prostate CancerTerminatedNCT00058214Phase 2Results posted
- Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen DeprivationTerminatedNCT00058188Phase 3Results posted
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased RiskCompletedNCT00056407Phase 3Results posted
- A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate CancerCompletedNCT00055471Phase 2Results posted
- Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00049257Phase 2Results posted
- Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate CancerCompletedNCT00040365Phase 2Results posted
- Radiation Therapy in Treating Patients With Stage II Prostate CancerCompletedNCT00033631Phase 3Results posted
- S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the ProstateCompletedNCT00030901Phase 3Results posted
- S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate CancerCompletedNCT00028769Phase 2Results posted
- Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate CancerTerminatedNCT00024167Phase 3Results posted
- Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate CancerCompletedNCT00017563Phase 2Results posted
- Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate CancerCompletedNCT00016913Phase 2Results posted
- Prostate Cancer Intervention Versus Observation Trial (PIVOT)CompletedNCT00007644Phase 3Results posted
- S0000 Selenium and Vitamin E in Preventing Prostate CancerCompletedNCT00006392Phase 3Results posted
- Eflornithine in Treating Patients At High Risk of Developing Prostate CancerCompletedNCT00006101Phase 2Results posted
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005947Phase 3Results posted
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00005044Phase 3Results posted
- Thalidomide for the Treatment of Hormone-Dependent Prostate CancerCompletedNCT00004635Phase 3Results posted
- S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate CancerCompletedNCT00004124Phase 3Results posted
- Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate CancerCompletedNCT00004054Phase 3Results posted
- Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for RecurrenceTerminatedNCT00003645Phase 3Results posted
- PET Scan in Treating Patients With Metastatic Prostate CancerCompletedNCT00002981Not applicableResults posted
- Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical ProstatectomyCompletedNCT00002874Phase 3Results posted
- SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate CancerCompletedNCT00002651Phase 3Results posted
- Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate CancerCompletedNCT00002597Phase 3Results posted
- Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)Active, not recruitingNCT00002540Not applicableResults posted
- Integrated ¹⁸F-PSMA-1007 PET/MR Combined With Diffusion-Relaxation Correlation Spectrum Imaging for Preoperative Prediction of Postoperative Adverse Pathology and High ISUP Grade in Prostate CancerActive, not recruitingNCT07887555
- RET-Targeted Molecular Imaging Probes in Prostate CancerActive, not recruitingNCT07886138Early Phase 1
- Hemodynamic Effects of Trendelenburg Position and Pneumoperitoneum in Urologic Robotic SurgeryCompletedNCT07848581
- Brief Title: INTROSPECT: Intraoperative PSMA PET/CT Imaging During Radical ProstatectomyActive, not recruitingNCT07829068Not applicable
- Robotic vs Laparoscopic and Open Surgery for Abdominopelvic CancersCompletedNCT07821775
- Hemodynamic Monitoring-Guided Goal-Directed Fluid Therapy in Robotic Radical ProstatectomyCompletedNCT07806539
- Dietary Fibre Supplementation to Delay Disease Progression in Early Prostate CancerCompletedNCT07790003
- Impact of Anterior Urethral Suspension Combined With Pelvic Fascia Reconstruction During Robot-Assisted Radical Prostatectomy on Early Postoperative Urinary Continence Recovery: A Single-Center, Prospective, Single-Arm Clinical StudyCompletedNCT07725653Not applicable
- Observing the Real-world Non-interventional Study of Abiraterone Acetate Tablets (II) in Treating Chinese Patients With Metastatic Prostate CancerActive, not recruitingNCT07721532
- Intraprostatic Anesthesia During Transperineal Prostate BiopsyActive, not recruitingNCT07683182Not applicable
- Dose-dEscalated MR-Guided Radiotherapy for Localized Prostate CancerActive, not recruitingNCT07674225Not applicable
- CoSMAP Trial: SP-EA vs MP-TA Robot-Assisted Radical ProstatectomyActive, not recruitingNCT07666217
- AI Multimodal Model for Predicting CRPC Progression RiskActive, not recruitingNCT07658573
- Dual-tracer PET Radiomics for Prostate Cancer StratificationCompletedNCT07655648
- Intelligent Screening and Precision Diagnosis of Prostate Cancer Based on Multimodal DataActive, not recruitingNCT07631806
- Predictors of Nodal and Distant Metastatic Disease Detected by PSMA PET in Treatment-Naïve High-Risk Prostate Cancer: A Czech Multicentre Cohort StudyActive, not recruitingNCT07608419
- Risk Factors, Incidence, and Progression of Lymphedema Among Men With Prostate Cancer. The AWARE CohortActive, not recruitingNCT07607431
- Clinically Actionable Tumor-Associated Antigens in Prostate CancerActive, not recruitingNCT07597369
- Study of ERW316 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid TumorsWithdrawnNCT07570966Phase 1/2
- Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)CompletedNCT07568444Phase 2
- Transurethral Periprostatectomy Treatment of Cancerous Prostate TissueCompletedNCT07561502Not applicable
- Robotic Telesurgery in UrologyWithdrawnNCT07541066Not applicable
- Ga-68 PSMA PET/CT vs mpMRI in Cognitive Prostate BiopsyCompletedNCT07533344
- A Tailored Polygenic Risk Score for Predicting Progression in Prostate Cancer Under Active SurveillanceCompletedNCT07491406
- Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate CancerCompletedNCT07489729Not applicable
- Molecular Profiling of MRI-PSMA PET Discordance in Prostate CancerCompletedNCT07485257
- A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated PatientsCompletedNCT07477756
- Effects of Music Therapy on Anxiety and Distress Levels During Radionuclide Treatment in Prostate Cancer PatientsCompletedNCT07464964Not applicable
- A Prolonged Nightly Fasting for Men on ADT for PCaCompletedNCT07462403Not applicable
- COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)Active, not recruitingNCT07455097
- A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617CompletedNCT07450157
- Turkish Version of the UCLA Prostate Cancer IndexCompletedNCT07448545
- Effect of Rectus Block Timing on Opioid UseCompletedNCT07433140Not applicable
- Sense of Coherence and Quality of Life in Prostate Cancer Patients Treated With Radical RadiotherapyActive, not recruitingNCT07431684Not applicable
- PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.CompletedNCT07428642
- Robot-Assisted Radical Prostatectomy: the HOOD Technique Versus Standard Anterior ReconstructionCompletedNCT07417475Not applicable
- Targeted Prostate Cancer Screening in Men With BRCA1/2 MutationsCompletedNCT07416812Not applicable
- Safety and Efficacy of PSMA-Targeted Fluorescent Contrast Agent DGPR1008 for Intraoperative Imaging in Robot-Assisted Radical ProstatectomyCompletedNCT07415135Phase 2
- Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic SurgeryCompletedNCT07413120Phase 3
- Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCaActive, not recruitingNCT07352748
- A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer DrugsActive, not recruitingNCT07336446Phase 1/2
- A Study of BMS986365 in Combination With Degarelix in People With Prostate CancerActive, not recruitingNCT07335796Phase 2
- Efficacy of the Pelvic Clock® Device for Functional Recovery After Robotic-Assisted Radical ProstatectomyCompletedNCT07333807Not applicable
- TENS for Pain Relief During Fusion-Guided Prostate BiopsyCompletedNCT07331246Not applicable
- AcuTENS for Pain Relief During TRUS-Guided Prostate BiopsyActive, not recruitingNCT07292337Not applicable
- AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)Active, not recruitingNCT07285694Phase 1/2
- DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised TherapyActive, not recruitingNCT07265414
- Comparison of Peak Expiratory Flow Changes After Robot-Assisted Versus Open Radical ProstatectomyActive, not recruitingNCT07262073Not applicable
- Effect of Changes in Endotracheal Tube Cuff Pressure on Postoperative Pharyngolaryngeal Complications in Robotic SurgeryCompletedNCT07242144
- Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM)WithdrawnNCT07237399
- Study of TRDC002 in the Diagnosis of Patients With PSMA-positive Prostate CancerActive, not recruitingNCT07236112Phase 1
- The Influence of Music on perceiVed paIn and leVels of Anxiety whiLe unDergoing transperIneal Prostate Biopsy: the VIVALDI TrialCompletedNCT07234097Not applicable
- Whole Food Plant-based Diet to Improve Outcomes in Prostate CancerCompletedNCT07220499Not applicable
- Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane ChemotherapyCompletedNCT07218718Not applicable